FDA decision on Tysabri pushed back
The FDA’s scheduled March 29 decision on Biogen Idec and Elan’s Tysabri will be delayed by as much as 90 ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.